Beyond PARP—POLθ as an anticancer target by Higgins, G, Boulton, S

The elementary functions : an algorithmic approach / by 345026 Higgins, G. Albert

Elucidating the role of transiently hypoxic tumour cells on radiation resistance by Higgins, G, Hammond, E

Anaemia prevalence and blood transfusion rates in patients receiving chemoradiation for head and neck cancer by Higgins, G, Junor, E

A siRNA screen to identify molecular determinants of tumour radiosensitivity by Higgins, G, Geoffrey Higgins

A new roadmap to improve translation of imaging biomarkers by Skwarski, M, Higgins, G

Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA) by McAteer, M, Higgins, G

Targeting tumour hypoxia: shifting focus from oxygen supply to demand by Coates, J, Skwarski, M, Higgins, G

Conventional radiotherapy or hypofractionation? A study of molecular changes resulting from different radiation fractionation schemes. by Hamilton, J, Higgins, G, Bernhard, E

Uncovering the influence of the FGFR1 pathway on glioblastoma radiosensitivity by Sayal, K, Higgins, G, Hammond, E

SP-0539: Biological precision in radiotherapy by McKenna, G, Muschel, R, Higgins, G

POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells by Belan, O, Sebald, M, Adamowicz, M, Higgins, G

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics by Herbert, K, Ashton, T, Prevo, R, Pirovano, G, Higgins, G

Myxopapillary ependymoma with intracranial metastases. by Higgins, G, Smith, C, Summers, D, Statham, P, Erridge, S

Oxidative phosphorylation as an emerging target in cancer therapy by Ashton, T, McKenna, W, Kunz-Schughart, L, Higgins, G

A role for human homologous recombination factors in suppressing microhomology-mediated end joining. by Ahrabi, S, Sarkar, S, Pfister, S, Pirovano, G, Higgins, G, Porter, A, Humphrey, T

Outcome analysis of 300 prostate cancer patients treated with neoadjuvant androgen deprivation and hypofractionated radiotherapy. by Higgins, G, McLaren, D, Kerr, G, Elliott, T, Howard, G

Survival and PSA relapse data after hypofiractionated radiotherapy for early stage prostate cancer by Law, A, Higgins, G, Kerr, G, Mclaren, D, Howard, G

A long and winding road: the role of chemotherapy for hormone-refractory prostate cancer. by Higgins, G, Stewart, G, McNeill, SA, McLaren, D

Overexpression of POLQ confers a poor prognosis in early breast cancer patients. by Higgins, G, Harris, A, Prevo, R, Helleday, T, Mckenna, W, Buffa, F